Stericycle, Inc. (NASDAQ:SRCL - Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 1,384,463 shares traded hands during mid-day trading, an increase of 39% from the previous session's volume of 997,538 shares.The stock last traded at $58.94 and had previously closed at $58.91.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on SRCL shares. Truist Financial lifted their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a "hold" rating in a research report on Tuesday, June 4th. Royal Bank of Canada restated a "sector perform" rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. StockNews.com initiated coverage on shares of Stericycle in a research report on Saturday, August 24th. They set a "hold" rating on the stock. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Stericycle from $135.00 to $142.00 and gave the stock an "outperform" rating in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $74.00.
Check Out Our Latest Report on Stericycle
Stericycle Stock Up 0.2 %
The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $5.48 billion, a price-to-earnings ratio of -268.14, a price-to-earnings-growth ratio of 3.21 and a beta of 1.11. The firm's fifty day simple moving average is $58.40 and its two-hundred day simple moving average is $53.68.
Stericycle (NASDAQ:SRCL - Get Free Report) last posted its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.04. The company had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. Sell-side analysts anticipate that Stericycle, Inc. will post 2.29 EPS for the current year.
Institutional Investors Weigh In On Stericycle
A number of institutional investors and hedge funds have recently made changes to their positions in SRCL. Pentwater Capital Management LP purchased a new stake in shares of Stericycle in the 2nd quarter valued at approximately $83,010,000. Magnetar Financial LLC purchased a new stake in shares of Stericycle in the 2nd quarter valued at approximately $81,596,000. Millennium Management LLC raised its stake in shares of Stericycle by 1,057.6% in the 2nd quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider's stock valued at $76,457,000 after acquiring an additional 1,201,653 shares during the period. Alpine Associates Management Inc. purchased a new stake in shares of Stericycle in the 2nd quarter valued at approximately $62,298,000. Finally, Capital Research Global Investors raised its stake in shares of Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider's stock valued at $296,762,000 after acquiring an additional 705,586 shares during the period. 98.82% of the stock is owned by hedge funds and other institutional investors.
Stericycle Company Profile
(
Get Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
